Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens

Autonomic & Autacoid Pharmacology
B J DavisR Chess-Williams

Abstract

Alpha1 -adrenoceptor antagonists can cause ejaculatory dysfunction as an adverse effect. Contractions of the human vas deferens are mediated via α1A -adrenoceptors, and this study investigated whether the low affinity state of this receptor (α1L -adrenoceptor) is involved in mediating contractions of this tissue. The potency of agonists and the affinity of receptor subtype selective antagonists were determined in functional experiments and in [(3) H]tamsulosin binding experiments to identify the α1 -adrenoceptor subtype population present in the human vas deferens. The α1A -adrenoceptor selective agonist A61603 was a full agonist and was 250-fold more potent than noradrenaline. Prazosin antagonized contractile responses to phenylephrine with a low affinity (pKd = 8.6). Only high concentrations of RS17053 antagonized responses to phenylephrine and yielded a relatively low affinity estimate of 7.0. BMY7378 (α1D -adrenoceptor selective) gave a low affinity estimate (pKd = 6.7), whilst tamsulosin (α1A - and α1D -adrenoceptor selective) had a high affinity (pKd = 9.9). [(3) H]Tamsulosin bound to human vas deferens membranes with a high affinity (pKd = 10.0). Prazosin, RS17053 and BMY7378 competed with [(3) H]tamsulosin with low affi...Continue Reading

References

Jan 16, 1995·European Journal of Pharmacology·A S GoetzD L Saussy
Sep 1, 1995·British Journal of Pharmacology·K FurukawaR Chess-Williams
Feb 15, 1997·The Prostate·K E AnderssonM G Wyllie
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Feb 12, 2005·BJU International·R Jeroen A van MoorselaarUNKNOWN ALF-ONE Study Group
Mar 11, 2006·Drugs·Marleen M van DijkMartin C Michel
Sep 6, 2006·The Journal of Urology·Wayne J G Hellstrom, Suresh C Sikka
Oct 3, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Shin-ichi HisasueTaiji Tsukamoto
Jan 29, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Teruhiko YokoyamaAtsushi Sone
Nov 9, 2011·British Journal of Pharmacology·Stephen P H AlexanderJohn A Peters
Dec 4, 2013·Proceedings of the National Academy of Sciences of the United States of America·Carl W WhiteSabatino Ventura

❮ Previous
Next ❯

Citations

Feb 6, 2019·British Journal of Pharmacology·Carl W WhiteSabatino Ventura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Related Papers

The Journal of Pharmacology and Experimental Therapeutics
Yasuko Hiraizumi-HiraokaI Muramatsu
The Journal of Pharmacology and Experimental Therapeutics
K TaguchiM C Michel
© 2021 Meta ULC. All rights reserved